Investors

p53 is a venture capital fund specializing in early-stage investments in the biotech and pharma sectors. They provide Series A funding, with investments ranging from $250,000 to $5 million. One of their portfolio companies is Calluna Pharma, demonstrating their commitment to advancing medical and pharmaceutical innovations.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Recent Investments